Bio

Dr. Davis joined Lincoln Park Capital in 2017 as a biotechnology analyst. Prior to joining the firm, he studied how gene regulatory networks control cellular behaviors as a biomedical researcher at the University of Chicago. This work culminated in several primary research publications, including predictions of the trajectory of regenerative medicine. During his graduate work, Dr. Davis also volunteered at local museums and outreach events to communicate scientific concepts to the public. He currently covers a wide range of topics in biotech from biologics and small molecule therapeutics to regenerative medicine and medical devices. Dr. Davis graduated from the University of Chicago in June of 2017 with a doctorate in Development, Regeneration, and Stem Cell Biology. He completed a B.S. in Biology, cum laude, with a minor in Violin Performance at Gonzaga University in May of 2010.